Stock listing
Immunic, Inc.
- Ticker
- NASDAQ:IMUX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Immunic, Inc.
Immunic, Inc. is a public company traded under the ticker IMUX in the American market. Immunic focuses on developing innovative therapies for autoimmune diseases.
Latest news from Immunic, Inc.
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
Oct 7, 2026
Immunic Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sep 29, 2026
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
Sep 2, 2026
Immunic Appoints Chitrang Davé as Chief Data and Digital Officer
Sep 1, 2026